Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVE: Breast cancer prognosis depends on early detection. We developed and externally validated a model using routine, readily available clinical and laboratory variables to discriminate malignant from benign breast lesions, aiming to reduce unnecessary biopsies and support early decision-making. METHODS: This retrospective two-center study included a development cohort 1from Jiujiang First P...
OBJECTIVE: Artificial intelligence (AI) applications have garnered increasing interest in obstetrics and gynecology. This study aims to analyze the evolving research themes, temporal trends, and conceptual frameworks of AI applications in this field through a comprehensive bibliometric analysis. METHODS: A total of 815 original research articles published between 1980 and 2025 were retrieved from ...
Chronic lymphocytic leukemia (CLL) is a highly heterogeneous B-cell malignancy, spanning a spectrum from indolent conventional forms (C-CLL) to Richte...
A growing number of diseases are now treated with immunotherapies, which consist of interventions that suppress or stimulate the patient's immune syst...
Non-small cell lung cancer (NSCLC) patient management relies on molecular analysis to determine eligibility for targeted therapy. Furthermore, neoadju...
PURPOSE: Aging and metabolic syndrome (MetS) are intertwined risk factors for breast cancer (BC), but the core molecular nexus integrating these state...
Spatial transcriptomics enables in situ mapping of gene expression, offering insights into tissue organization and cell-cell interactions. However, it...
Accurate prognostic prediction for colorectal cancer is essential for optimizing personalized treatment strategies and improving patient outcomes. Cur...
Histopathological hematoxylin and eosin (H&E) slides contain valuable prognostic information for pancreatic ductal adenocarcinoma (PDAC), yet systemat...
Serous effusions, including pleural effusion and ascites, commonly occur in advanced cancers like lung and ovarian carcinomas. Detecting tumor cells i...
PURPOSE: Preoperative assessment of pathologic complete response (pCR) to neoadjuvant therapy is an urgent need for anorectal preservation in patients...
BACKGROUND: Data on neoadjuvant treatment with trastuzumab biosimilars, particularly CT-P6, in combination with pertuzumab, are limited. This study ev...
PURPOSE: This study aimed to investigate the feasibility of combining high-frequency reconstruction kernels and deep-learning image reconstruction at ...
The mucosa-associated lymphoid tissue lymphoma-translocation protein 1 (MALT1) is a key protein in the adaptive immune response system in humans. This...
Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality, yet the role of N-glycosylation in its pathogenesis remains unclear. We applied...
The Response Evaluation Criteria in Solid Tumors (RECIST 1.1) protocol is the gold standard for assessing treatment response in oncological clinical t...
Acute myeloid leukemia (AML) is a clinically aggressive hematologic malignancy driven by complex genetic and epigenetic aberrations. Circular RNAs (ci...
BACKGROUND: Magnetic resonance imaging (MRI) is widely used for the diagnosis, evaluation, and follow-up of intestinal diseases. With advances in arti...
BACKGROUND: Non-muscle-invasive bladder cancer (NMIBC) has a high risk of recurrence, and multiple surgeries increase the disease burden on patients. ...
BACKGROUND: Biomechanical features show notable heterogeneity in tumor risk stratification, yet their role in prostate cancer (PCa) progression remain...